| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.032 | 0.4 |